Dr. Ali Al-Ghamrawy, Chairman of the Egyptian Drug Authority, received Dr. Isabel Afonso, CEO of Arcera Global, Dr. Mohamed Heshmat, General Manager of Amoun Pharmaceutical Company, a subsidiary of the Emirates Holding Company ADQ - Arcera - Abu Dhabi Investment Fund, and representatives from the company at the headquarters of the Egyptian Drug Authority, to discuss enhancing joint cooperation and increasing the production of pharmaceutical products produced by the company in the Egyptian pharmaceutical market.
Dr. Ali Al-Ghamrawy welcomed the company's delegation, emphasizing the Egyptian Drug Authority's commitment to strengthening its partnership with Amoun to enhance the Egyptian market and expand pharmaceutical exports.
He highlighted Egypt’s strong pharmaceutical sector, known for its high-quality, competitively priced products and strategic location as a key export gateway to Africa.